Circulating biomarkers for vascular endothelial growth factor inhibitors in renal cell carcinoma. - Wikidata - wikimedia - TriplyDB

Circulating biomarkers for vascular endothelial growth factor inhibitors in renal cell carcinoma.

Circulating biomarkers for vascular endothelial growth factor inhibitors in renal cell carcinoma.

http://www.wikidata.org/entity/Q37463927

about

CD133+ circulating haematopoietic progenitor cells predict for response to sorafenib plus erlotinib in non-small cell lung cancer patients.The BATTLE to personalize lung cancer prevention through reverse migration.A cytokine and angiogenic factor (CAF) analysis in plasma for selection of sorafenib therapy in patients with metastatic renal cell carcinoma Plasma cytokine and angiogenic factor profiling identifies markers associated with tumor shrinkage in early-stage non-small cell lung cancer patients treated with pazopanib Adjuvant and neoadjuvant therapy in renal cell carcinoma.A Pharmacometric Framework for Axitinib Exposure, Efficacy, and Safety in Metastatic Renal Cell Carcinoma Patients.Anti-angiogenesis target therapy for advanced osteosarcoma (Review).Phase 1 trial of ontuxizumab (MORAb-004) in children with relapsed or refractory solid tumors: A report from the Children's Oncology Group Phase 1 Pilot Consortium (ADVL1213).

P2860

Q33630819-FFDD3828-A955-4368-A1FA-90CBD9CD8522 Q35208501-5674BF51-9454-4302-9533-8C56B40FD1AD Q35747277-D7C4E042-1344-487C-8FE2-FEECA90CEE7B Q35883400-2220D36D-41F8-43CB-88D3-49BA649ED0DC Q37492442-0F855FA7-7ECD-4A2C-8C78-2E95E7408962 Q38378485-B31B07F9-9D24-433C-A3DA-D3D32506BCBE Q39401628-12841481-CF32-4AD5-9943-5EB22068C4A1 Q48324213-5B9014C2-CB53-4662-9CBB-8E882998996C

P2860

Circulating biomarkers for vascular endothelial growth factor inhibitors in renal cell carcinoma.

http://www.wikidata.org/entity/Q37463927

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on May 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Circulating biomarkers for vas ...... itors in renal cell carcinoma.

@en

Circulating biomarkers for vas ...... itors in renal cell carcinoma.

@nl

type

label

Circulating biomarkers for vas ...... itors in renal cell carcinoma.

@en

Circulating biomarkers for vas ...... itors in renal cell carcinoma.

@nl

prefLabel

Circulating biomarkers for vas ...... itors in renal cell carcinoma.

@en

Circulating biomarkers for vas ...... itors in renal cell carcinoma.

@nl

P1433

Q37463927-0C08025A-BEDA-4802-9FDE-6CE552E6BE6B

P1476

Q37463927-BA068DF0-0C0B-402A-97DA-840517469DB8

P2093

Q37463927-5504B77E-56C4-4D9D-871D-8C07DFBA7B0A

Q37463927-6646CFF2-F9F5-475F-ACBC-4EDF88F1D2CC

Q37463927-8E842F87-54E9-4EED-BFDB-3B7CCD3244B1

Q37463927-947E9FE0-5E44-4EF8-A3F5-A2C1CBE65DE7

P2860

Q37463927-0255268E-81B1-4C87-994E-E2BDD451D79D

Q37463927-033D024B-4284-4A5E-9F2C-73EAF6E896B5

Q37463927-049E1D87-16A7-4798-BDB9-7AA40A855823

Q37463927-124D6F82-9809-4C85-9426-95C0A0084234

Q37463927-1352A534-9E1A-478C-A517-F46D9A0D04C1

Q37463927-17564211-ED98-4B59-BF22-2BC9608A4E6B

Q37463927-21915237-C8BA-401F-B322-28DF2A06DC11

Q37463927-24ABF101-41ED-4371-9E69-A27089752B2E

Q37463927-28B6D4AE-E6C9-4505-948C-AE0AFA5E9E41

Q37463927-2AC7E429-86F3-4604-AF0D-9361C4404422

P304

Q37463927-98FA1615-931E-41A9-BC91-85BC4AFEEC4D

P31

Q37463927-613A5862-E94A-4672-B89F-640AAD9D5B95

P356

Q37463927-B5966E76-189E-440B-A183-326F9E6604E6

P407

Q37463927-977B4B6B-BF36-4CFE-B513-89CE87AE64DC

P433

Q37463927-FFCE9358-17CD-45D4-91C4-7EC1D596BD0E

P478

Q37463927-339128CF-826F-427E-97BF-4F44CE8D9321

P50

Q37463927-C4621DA0-D910-465E-AFA0-02E9B59E6B47

P577

Q37463927-3619DF2A-AA52-46A0-83F9-D8ADC25899E0

P5875

Q37463927-CED6839F-31C3-4516-930D-03E2F79B5486

P698

Q37463927-7F7141AE-3A94-4EBD-A59D-91C70C2C081B

P921

Q37463927-D80B99AB-8A54-455C-A511-EAE4BFBFC2EE

Q37463927-F10402DC-260E-4112-8872-B1E22FF7F69A

P932

Q37463927-44F9F450-EC2D-4E45-8F14-3766BBB1E577

P356

P1433

P1476

Circulating biomarkers for vas ...... itors in renal cell carcinoma.

@en

P2093

Amado J Zurita

http://www.w3.org/2001/XMLSchema#string

Eric Jonasch

http://www.w3.org/2001/XMLSchema#string

Hai T Tran

http://www.w3.org/2001/XMLSchema#string

Hua-Kang Wu

http://www.w3.org/2001/XMLSchema#string

P2860

Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor

Origins of circulating endothelial cells and endothelial outgrowth from blood

Targeting HIF-1 for cancer therapy

Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

Sorafenib in advanced clear-cell renal-cell carcinoma

Isolation of putative progenitor endothelial cells for angiogenesis

Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis

Angiogenesis as a therapeutic target

Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes

P304

2346-2354

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCR.24228

http://www.w3.org/2001/XMLSchema#string

P407

P433

10 Suppl

http://www.w3.org/2001/XMLSchema#string

P478

115

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24376939

http://www.w3.org/2001/XMLSchema#string

P698

19402074

http://www.w3.org/2001/XMLSchema#string

P921

P932

4407476

http://www.w3.org/2001/XMLSchema#string